iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://www.ncbi.nlm.nih.gov/pubmed/12700435
[Risks of antibacterial agents in pregnancy] - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Mar;10(1):8-15.

[Risks of antibacterial agents in pregnancy]

[Article in Italian]
Salvatore Nardiello  1 , Teresa Pizzella, Rosanna Ariviello
Affiliations
  • PMID: 12700435
Free article
Review

[Risks of antibacterial agents in pregnancy]

[Article in Italian]
Salvatore Nardiello et al. Infez Med. 2002 Mar.
Free article

Abstract

Antimicrobial therapy in the pregnant woman has to consider the potential risks of antibacterial agents for the developing foetus and the mother. Extensive clinical experience shows that penicillins, cephalosporins and erythromycin (except erythromycin estolate) can be considered safe for the developing foetus and for the pregnant woman. Nitrofurantoin is a valid antibacterial option in pregnancy, except in the latter stages. Isoniazid and ethambutol are the safest drugs for the treatment of tuberculosis in pregnancy, but attention must be paid to the potential toxicity of isoniazid for the mother. For several other antimicrobial agents (aminoglycosides, fluoroquinolones, newer macrolides, metronidazole, rifampicin, vancomycin) a potential teratogenic or toxic risk has been documented in animal or human studies: however, their use during pregnancy is justified when there is no safer alternative. A few antibacterials should be absolutely avoided in pregnancy: tetracyclines, cotrimoxazole and chloramphenicol according to a teratogenic risk or a toxic risk for the foetus or the mother, and clindamycin according to its high risk/benefits ratio. The safety data in pregnancy of many other antibacterials, including carbapenems, ketolides and streptogramines, are very limited or lacking. More data on the risks of antibacterial agents are needed for an optimal therapy of bacterial infections in pregnancy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

Substances

LinkOut - more resources